Operated by Ieldas Inc. · Independent methodology · Affiliate-supported. Read our ownership & funding disclosure and how every figure is verified.
GLP1ProviderFinderUS price records
HomeBlog › MEDVi Review 2026

Journal · Updated 2026-08-11

MEDVi Review 2026: $299/$399, and the Case That Has to Be Made at Intake

By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify

Short answer — August 2026

MEDVi prices at the compounded market's upper shelf — two ninety-nine semaglutide, three ninety-nine tirzepatide, provider-stated — the same altitude as Remedy, with the same structural consequence: the brand products sit close enough above (four forty-nine maintenance vials, three forty-nine pens, one forty-nine tablets) that the compounded value case must be made explicitly rather than assumed. Our records carry no itemized bundle making it, which routes the review through three intake questions rather than a verdict.

The three questions, and placement

What does the price include beyond medication — visit cadence, support access, anything a one-seventy-nine program doesn't bundle; which pharmacy fills my prescription — the fifteen-minute verification applies with full force at premium prices; and why this over the approved product — a question worth asking the program directly, since a good operator at this tier should have a fluent answer about formulation, dosing flexibility, or service. Placement against the field: two-forty over the tirzepatide flat tier, one-seventy over the semaglutide floor, and inside fifty dollars of both brand benchmarks — arithmetic that makes MEDVi a specific-reason purchase. Cleared questions plus a specific reason: defensible. Either missing: the board offers the same molecule at half the price below, or the certainty of approval for slightly more above.

Questions people ask

How much is MEDVi?

$299/month for compounded semaglutide and $399 for tirzepatide, provider-stated — upper-shelf compounded pricing, within $50 of the FDA-approved brand benchmarks on both molecules.

Is MEDVi cheaper than Zepbound?

Barely: $399 vs $449 at maintenance ($50), and more than Zepbound's $299/$399 titration rungs. At that spread, the approved product's sealed dosing and agency review win most cases unless MEDVi articulates a specific formulation or service reason at intake.

What should I ask MEDVi before enrolling?

Three things in writing: what the price includes beyond medication; the pharmacy name (then verify licenses and request a COA); and the program's own answer to 'why this over the brand at these prices.' Premium tiers earn their premium in those answers or not at all.

This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.